-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Downgrades United Therapeutics to Equal-Weight, Lowers Price Target to $314

Benzinga·04/25/2025 11:16:25
Listen to the news
Wells Fargo analyst Tiago Fauth downgrades United Therapeutics (NASDAQ:UTHR) from Overweight to Equal-Weight and lowers the price target from $395 to $314.